Enzymotec Ltd. to Participate in the Jefferies 2015 Global Healthcare Conference
May 20 2015 - 7:30AM
Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a
developer, manufacturer and marketer of innovative bio-active lipid
ingredients, announced today that Dr. Ariel Katz, President and
Chief Executive Officer, will present at the Jefferies 2015 Global
Healthcare Conference on Tuesday, June 2, 2015 at 1:30 p.m. ET at
the Grand Hyatt in New York City.
The conference presentation will be broadcast over the Internet
as a "live" listen only webcast. To listen, please go to Investors
section of the Company's website at www.enzymotec.com. An archive
of the event will also be available for those unable to listen
live.
About Enzymotec Ltd.
Enzymotec is a leading global supplier of specialty lipid-based
products and solutions. The Company develops, manufactures and
markets innovative bio-active lipid ingredients, as well as final
products, based on sophisticated processes and technologies. For
more information, visit www.enzymotec.com.
CONTACT: KCSA Strategic Communications
Jeffrey Goldberger / Tram Bui
212.896.1249 / 212.896.1290
ENZY@kcsa.com
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jun 2024 to Jul 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Enzymotec Ltd. - Ordinary Shares (delisted) (NASDAQ): 0 recent articles
More News Articles